POLYPLUS TRANSFECTION is a biotech company that develops and markets innovative solutions for in vivo, in vitro and ex vivo transfer of nucleic acids for research, bio-production and therapeutic use.
Our reagents are involved in a growing number of clinical trials.
POLYPLUS-TRANSFECTION has patents and licences for several innovative approaches to deliver siRNA for therapeutic use.
Web site: https://www.polyplus-transfection.com/
Contact email: firstname.lastname@example.org
Name and surname of contact person: Gabriel Festoc